Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Debt to Equity Ratio: 0.6151 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.6151 |
| June 30, 2024 | 0.6472 |
| March 31, 2024 | 0.7308 |
| December 31, 2023 | 0.736 |
| September 30, 2023 | 0.7605 |
| June 30, 2023 | 0.8237 |
| March 31, 2023 | 0.8826 |
| December 31, 2022 | 0.9097 |
| September 30, 2022 | 1.108 |
| June 30, 2022 | 1.120 |
| March 31, 2022 | 1.016 |
| December 31, 2021 | 1.051 |
| September 30, 2021 | 1.182 |
| June 30, 2021 | 1.165 |
| March 31, 2021 | 0.9966 |
| December 31, 2020 | 0.9211 |
| September 30, 2020 | 1.047 |
| June 30, 2020 | 1.274 |
| March 31, 2020 | 1.420 |
| December 31, 2019 | 1.136 |
| September 30, 2019 | 1.231 |
| June 30, 2019 | 1.404 |
| March 31, 2019 | 1.103 |
| December 31, 2018 | 1.244 |
| September 30, 2018 | 1.344 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.546 |
| March 31, 2018 | 0.9938 |
| December 31, 2017 | 1.096 |
| September 30, 2017 | 1.158 |
| June 30, 2017 | 1.187 |
| March 31, 2017 | 1.366 |
| December 31, 2016 | 1.476 |
| September 30, 2016 | 1.451 |
| June 30, 2016 | 1.642 |
| March 31, 2016 | 1.105 |
| December 31, 2015 | 1.177 |
| September 30, 2015 | 1.210 |
| June 30, 2015 | 1.101 |
| March 31, 2015 | 1.185 |
| December 31, 2014 | 1.149 |
| September 30, 2014 | 1.174 |
| June 30, 2014 | 1.211 |
| March 31, 2014 | 0.9214 |
| December 31, 2013 | 1.036 |
| September 30, 2013 | 0.9756 |
| June 30, 2013 | 0.9815 |
| March 31, 2013 | 1.033 |
| December 31, 2012 | 1.109 |
| September 30, 2012 | 1.119 |
| June 30, 2012 | 1.219 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6151
Minimum
Sep 2024
1.420
Maximum
Mar 2020
0.9771
Average
1.006
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| CVS Health Corp | 0.8744 |
| Arbutus Biopharma Corp | 0.00 |
| FibroBiologics Inc | -- |
| Biomarin Pharmaceutical Inc | 0.1098 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.004B |
| Total Liabilities (Quarterly) | 4.176B |
| Shareholders Equity (Quarterly) | 3.782B |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 0.70% |